Sarah Jean Nechuta

Dr. Sarah Jean Nechuta

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2011 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
JBJeannette M. Beasley
Jeannette M. Beasley
MKMarilyn L. Kwan
Marilyn L. Kwan
WCWendy Y. Chen
Wendy Y. Chen
EWErin K. Weltzien
Erin K. Weltzien
CKCandyce H. Kroenke
Candyce H. Kroenke
BCBette J. Caan
Bette J. Caan

1 July 2012 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
Sarah Jean NechutaSarah Jean Nechuta
Sarah Jean Nechuta
BCBette J Caan
Bette J Caan
WCWendy Y Chen
Wendy Y Chen
WLWei Lu
Wei Lu
ZCZhi Chen
Zhi Chen
XSXiao-Ou Shu
Xiao-Ou Shu
Background: Soy isoflavones have antiestrogenic and anticancer properties but also possess estrogen-like properties, which has raised concern about s

25 November 2015 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
Sarah Jean NechutaSarah Jean Nechuta
Sarah Jean Nechuta
WCWendy Y. Chen
Wendy Y. Chen
Hui CaiHui Cai
Hui Cai
EPElizabeth M. Poole
Elizabeth M. Poole
MKMarilyn L. Kwan
Marilyn L. Kwan
XSXiao Ou Shu
Xiao Ou Shu
Lifestyle factors have been well studied in relation to breast cancer prognosis overall; however, associations of lifestyle and late outcomes (>5 years after diagnosis) have been much less studied, and no studies have focused on estrogen receptor‐positive (ER+) breast cancer survivors, who may have high risk of late recurrence and mortality. We utilized a large prospective pooling study to evaluate the associations of lifestyle factors with late recurrence and all‐cause mortality among 6,295 5‐year ER+ Stage I–III breast cancer survivors. Pooled and harmonized data were available on clinical factors and lifestyle factors (pre‐ to post‐diagnosis weight change, body mass index (BMI) (kg/m2), recreational physical activity, alcohol intake and smoking history), measured on average 2.1 years after diagnosis. Updated information for weight only was available. Study heterogeneity was evaluated by the Q‐statistic. Multivariable Cox regression models were stratified by study. Adjusting for clinical factors and potential confounders, ≥10% weight gain and obesity (BMI, 30–34.99 and ≥35) were associated with increased risk of late recurrence (hazard ratios (95% confidence intervals): 1.24 (1.00–1.53), 1.40 (1.05–1.86) and 1.41 (1.02–1.93), respectively). Daily alcohol intake was associated with late recurrence, 1.28 (1.01–1.62). Physical activity was inversely associated with late all‐cause mortality (0.81 (0.71–0.93) and 0.71 (0.61–0.82) for 4.9 to <17.4 and ≥17.4 metabolic equivalent‐hr/week). A U‐shaped association was observed for late all‐cause mortality and BMI using updated weight (1.42 (1.15–1.74) and 1.40 (1.09–1.81), <21.5 and ≥35, respectively). Smoking was associated with increased risk of late outcomes. In this large prospective pooling project, modifiable lifestyle factors were associated with late outcomes among long‐term ER+ breast cancer survivors.

21 December 2011 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MKMarilyn L. Kwan
Marilyn L. Kwan
WCWendy Y. Chen
Wendy Y. Chen
CKCandyce H. Kroenke
Candyce H. Kroenke
EWErin K. Weltzien
Erin K. Weltzien
JBJeannette M. Beasley
Jeannette M. Beasley
BCBette J. Caan
Bette J. Caan

1 May 2017 in Journal of Women's Health
Verified
Journal Article
Closed access
JLJasmine D. Lee
Jasmine D. Lee
QCQiuyin Cai
Qiuyin Cai
XSXiao Ou Shu
Xiao Ou Shu
Sarah Jean NechutaSarah Jean Nechuta
Sarah Jean Nechuta
Background: Oxidative stress may play an important role in both initiation and progression of breast cancer. We conducted the first systematic epidemiologic review to summarize the published literature on oxidative stress biomarkers and breast cancer. Materials and Methods: We implemented systematic search strategies to identify published studies of oxidative stress biomarkers and (1) risk of developing breast cancer and (2) breast cancer prognosis using the PRISMA statement guidelines. Results: We identified eleven case–control studies of oxidative stress biomarkers and breast cancer. Biomarkers utilized varied and menopausal status was a key modifying factor. Across three nested case–control studies with biomarkers measured before diagnosis, one reported increased risk of postmenopausal breast cancer in association with 8-oxodG (DNA damage biomarker), while two (one of F2-isoprostanes and one of fluorescent oxidation products) reported inverse associations for premenopausal breast cancer only. We identified eight prognostic studies. Two reported associations for lipid peroxidation and breast cancer prognosis; results for other studies were null. Conclusions: DNA damage may increase risk of breast cancer among postmenopausal women, while lipid peroxidation may be inversely associated with premenopausal breast cancer. Lipid peroxidation may be associated with survival after breast cancer diagnosis; however, results require evaluation in large, prospective cohort studies.

1 August 2012 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
BCBette J. Caan
Bette J. Caan
MKMarilyn L. Kwan
Marilyn L. Kwan
XSXiao Ou Shu
Xiao Ou Shu
JPJohn P. Pierce
John P. Pierce
RPRuth E. Patterson
Ruth E. Patterson
WCWendy Y. Chen
Wendy Y. Chen
Background: Weight change after a breast cancer diagnosis has been linked to lower survival. To further understand effects of postdiagnostic weight variation on survival, we examined the relationship by comorbid status and initial body mass index (BMI). Methods: The current analysis included 12,915 patients with breast cancer diagnosed between 1990 and 2006 with stage I–III tumors from four prospective cohorts in the United States and China. HRs and 95% confidence intervals (CI) representing the associations of five weight change categories [within <5% (reference); 5%–<10% and ≥10% loss and gain] with mortality were estimated using Cox proportional hazards models. Results: Mean weight change was 1.6 kg. About 14.7% women lost and 34.7% gained weight. Weight stability in the early years postdiagnosis was associated with the lowest overall mortality risk. Weight loss ≥10% was related to a 40% increased risk of death (HR, 1.41; 95% CI, 1.14–1.75) in the United States and over three times the risk of death (HR, 3.25; 95% CI: 2.24, 4.73) in Shanghai. This association varied by prediagnosis BMI, and in the United States, lower survival was seen for women who lost weight and had comorbid conditions. Weight gain ≥10% was associated with a nonsignificant increased risk of death. Conclusions: Prevention of excessive weight gain is a valid public health goal for breast cancer survivors. Although intentionality of weight loss could not be determined, women with comorbid conditions may be particularly at risk of weight loss and mortality. Impact: Weight control strategies for breast cancer survivors should be personalized to the individual's medical history. Cancer Epidemiol Biomarkers Prev; 21(8); 1260–71. ©2012 AACR.